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2009;74:598–605.Going Over LEGACY With
a Pinch of SaltPathak et al. (1) reported that sustained weight loss
$10% in patients with a body mass index $27 kg/m2
was associated with a 6-fold reduction of atrial
ﬁbrillation (AF) recurrence during a 5-year follow-up,
compared to patients without weight loss. The non-
randomized design and statistical methods used raise
concerns about the extent to which the ﬁndings can
be considered valid.
The study was based on a post-hoc analysis of 355
patients, allocated to groups for comparison after
study completion according to the achieved weight
loss. We detected several potential sources of selec-
tion bias for these groups. Most importantly, patients
with the highest weight loss participated more
often in the offered dietician consulting, suggest-
ing generally better lifestyle management and drugtreatment compliance, which could also possibly
comprise a better control of other AF relevant com-
orbidities such as hypertension, obstructive sleep
apnea, or diabetes. Indeed, important information on
these comorbidities are missing, eliminating the
potential to assess their impact on AF: 1) classes and
doses of the antihypertensive drugs (rather than their
number per patient); 2) changes in apnea-hypopnea
index at follow-up; and 3) data on HbA1c at baseline
and follow-up (rather than fasting insulin levels that
do not inform about longer-term glycemic control).
Furthermore, patients with the highest weight loss
tended to be older than the control group. More de-
tails regarding AF treatment would also be helpful in
interpreting the results, since electrocardioversion,
number of ablations, and/or use of amiodarone at any
time could have inﬂuenced the maintenance of sinus
rhythm more robustly than sotalol or ﬂecainide use
alone. It is not clear whether the outcome was
adjusted for these variables.
Another form of bias includes attrition bias: the
information on the number and nature of dropouts is
missing. Although the authors aimed for a 5-year
follow-up, the average follow-up was 48 months for
unclear reasons. Dropouts due to death—especially in
older subjects (i.e., those with the highest weight
loss)—would have affected the outcome. In any study,
death can prevent detection of cause-speciﬁc nonfatal
endpoints. Hence an analysis combining AF recur-
rence and death is warranted as sensitivity analysis.
In our opinion, evaluating the real effect of weight
loss on AF would need a randomized controlled
study. Short of this, use of case-mix adjustments,
such as the propensity score matching, could provide
a better control for confounding.*Miroslava Valentova, MD
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